MIAMI--(BUSINESS WIRE)--Fagron North America, a leading supplier of compounded medications to hospital pharmacies and patients, will open one of the largest 503B human drug outsourcing facilities in ...
Fagron, the leading global player in pharmaceutical compounding, is pleased to announce the completion of University Compounding Pharmacy (UCP), a 503A pharmaceutical compounder focused on the health ...
Fagron, the leading global player in pharmaceutical compounding, is pleased to announce two strategic acquisitions that further strengthen its global footprint and diversify its capabilities. These ...
Fagron (ENXTBR:FAGR) shareholders approved all resolutions at the Annual and Extraordinary General Meetings. The meetings ...
PHOENIX--(BUSINESS WIRE)--Pete Pharma, a pharmaceutical innovation and IP development company focused on modernizing dosage forms through advanced 3D pharmaceutical printing, delivery systems, and ...
Fagron, the leading global player in pharmaceutical compounding, launches DiluCap, a new line of six excipients for compounding pharmacies allowing for easier and faster capsule formulation. Choosing ...
BRUSSELS, April 9 (Reuters) - Pharmaceutical compounding group Fagron is in talks to make acquisitions in Europe, the United States and Brazil, the group's chief executive said on Thursday. The group, ...
May 2026 - 6PM CET Fagron shareholders approve all proposed resolutions at the General Meetings Fagron, the leading global player ...
Nazareth (Belgium)/Rotterdam (The Netherlands), 12 January 2026 - 7:00 AM CET Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America Fagron, the leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results